No evidence that Fluad caused Italian deaths, says EMA
This article was originally published in Scrip
The European Medicines Agency's pharmacovigilance risk assessment committee (PRAC) says there is no evidence that Novartis' flu vaccine, Fluad, caused the serious adverse events, including deaths, that led the Italian authorities to suspend two batches of the product at the end of November.
You may also be interested in...
New guidance from the UK regulator covers distribution and deployment of Pfizer/BioNTech's COVID-19 vaccine, which will be complex because of the temperature storage requirements and the large packs in which the vaccine doses will be delivered.
The UK’s rapid authorization of the Pfizer/BioNTech COVID-19 vaccine has sparked a public debate over regulatory processes at some of the world’s key regulatory bodies.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.